StockNews.AI
JAGX
StockNews.AI
146 days

Jaguar Health CEO, Board Members, Other C-Suite Members, and Institutional and Accredited Investors Invest in $3.448 Million Bridge Financing Priced At-The-Market Under Nasdaq Rules

1. Jaguar Health is raising $3.448 million through convertible promissory notes. 2. The notes have a 3-month maturity and 6% annual interest rate.

2m saved
Insight
Article

FAQ

Why Bullish?

The financing through convertible notes indicates investor confidence, potentially supporting JAGX’s growth plans. Historical examples, like Tesla’s convertible debt issuance, showed positive price momentum post-announcement.

How important is it?

The issuance of convertible promissory notes is a strategic move that may enhance liquidity and investor sentiment, affecting JAGX's stock price positively in the near term.

Why Short Term?

The immediate nature of the financing and the short maturity of the notes suggest a fast impact on stock liquidity and market perception.

Related Companies

TSLAAMGNJNJ
SAN FRANCISCO, CA / ACCESS Newswire / March 26, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), announced today that Jaguar's president and chief executive officer Lisa Conte, three other members of the Company's board of directors, and seven other C-suite and senior executives of Jaguar along with selected institutional and accredited investors (each, an "Investor") entered into securities purchase agreements, pursuant to which the Company will issue up to $3.448 million aggregate principal amount of convertible promissory notes (collectively, the "Notes") to such Investors in a private placement priced at-the-market under Nasdaq rules. The Notes will have a 3-month maturity, will bear interest at 6% per annum, and will be convertible immediately at the option of the Investors into shares of the Company's common stock.

Related News